FLOT2 and breast cancer: FLOT2 overexpression is reported to be associated with the tumor grade, TNM stage, distant metastasis in multiple malignancies and can be useful as a prognostic biomarker for breast cancer progression (Liu et al. 2018; Wang et al. 2013).